These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15877777)

  • 1. Cost of anxiety disorders in Europe.
    Andlin-Sobocki P; Wittchen HU
    Eur J Neurol; 2005 Jun; 12 Suppl 1():39-44. PubMed ID: 15877777
    [No Abstract]   [Full Text] [Related]  

  • 2. Modelling the population cost-effectiveness of current and evidence-based optimal treatment for anxiety disorders.
    Issakidis C; Sanderson K; Corry J; Andrews G; Lapsley H
    Psychol Med; 2004 Jan; 34(1):19-35. PubMed ID: 14971624
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Economic costs of anxiety disorders.
    DuPont RL; Rice DP; Miller LS; Shiraki SS; Rowland CR; Harwood HJ
    Anxiety; 1996; 2(4):167-72. PubMed ID: 9160618
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-outcome of anxiety treatment intervention in primary care in Hungary.
    Zámbori J; Szádóczky E; Rózsa S; Füredi J
    J Ment Health Policy Econ; 2002 Sep; 5(3):115-20. PubMed ID: 12728198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Economic and epidemiologic aspects of generalized anxiety disorder: a review of the literature].
    Albarracin G; Rovira J; Carreras L; Rejas J
    Actas Esp Psiquiatr; 2008; 36(3):165-76. PubMed ID: 18478457
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cost of treating anxiety: the medical and demographic correlates that impact total medical costs.
    Marciniak MD; Lage MJ; Dunayevich E; Russell JM; Bowman L; Landbloom RP; Levine LR
    Depress Anxiety; 2005; 21(4):178-84. PubMed ID: 16075454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Incapacity for work and disability pensions in persons with mental disorders].
    Rymaszewska J; Dziełak K; Kiejna A
    Psychiatr Pol; 2007; 41(2):171-80. PubMed ID: 17598427
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Manifesto for a European anxiety disorders research network.
    Baldwin DS; Allgulander C; Altamura AC; Angst J; Bandelow B; den Boer J; Boyer P; Davies S; Dell'osso B; Eriksson E; Fineberg N; Fredrikson M; Herran A; Maron E; Metspalu A; Nutt D; van der Wee N; Vázquez-Barquero JL; Zohar J
    Eur Neuropsychopharmacol; 2010 Jun; 20(6):426-32. PubMed ID: 20356717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medical and productivity costs of anxiety disorders: case control study.
    Marciniak M; Lage MJ; Landbloom RP; Dunayevich E; Bowman L
    Depress Anxiety; 2004; 19(2):112-20. PubMed ID: 15022146
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generalized anxiety disorder: issues in epidemiology.
    Brawman-Mintzer O; Lydiard RB
    J Clin Psychiatry; 1996; 57 Suppl 7():3-8. PubMed ID: 8690694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost of anxiety disorders in Japan in 2008: a prevalence-based approach.
    Sado M; Takechi S; Inagaki A; Fujisawa D; Koreki A; Mimura M; Yoshimura K
    BMC Psychiatry; 2013 Dec; 13():338. PubMed ID: 24350841
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reducing the number of emergency department visits and costs associated with anxiety: a randomized controlled study.
    Kolbasovsky A; Reich L; Futterman R; Meyerkopf N
    Am J Manag Care; 2007 Feb; 13(2):95-102. PubMed ID: 17286529
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Rehabilitation programs in psychiatry and the criteria for assessing their effectiveness (a review of the literature)].
    Stiazhkin DD
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1987; 87(9):1412-9. PubMed ID: 3321801
    [No Abstract]   [Full Text] [Related]  

  • 14. Human and economic burden of generalized anxiety disorder.
    Hoffman DL; Dukes EM; Wittchen HU
    Depress Anxiety; 2008; 25(1):72-90. PubMed ID: 17146763
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost of depression in Europe.
    Sobocki P; Jönsson B; Angst J; Rehnberg C
    J Ment Health Policy Econ; 2006 Jun; 9(2):87-98. PubMed ID: 17007486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost of psychotic disorders in Europe.
    Andlin-Sobocki P; Rössler W
    Eur J Neurol; 2005 Jun; 12 Suppl 1():74-7. PubMed ID: 15877784
    [No Abstract]   [Full Text] [Related]  

  • 17. Use of health services for major depressive and anxiety disorders in Finland.
    Hämäläinen J; Isometsä E; Sihvo S; Pirkola S; Kiviruusu O
    Depress Anxiety; 2008; 25(1):27-37. PubMed ID: 17238158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of first eye cataract surgery on mental health contacts for depression and/or anxiety: a population-based study using linked data.
    Meuleners LB; Hendrie D; Fraser ML; Ng JQ; Morlet N
    Acta Ophthalmol; 2013 Sep; 91(6):e445-9. PubMed ID: 23586972
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of anxiety disorders.
    Bienvenu OJ; Ginsburg GS
    Int Rev Psychiatry; 2007 Dec; 19(6):647-54. PubMed ID: 18092242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Nottingham study of neurotic disorder: predictors of 12 year costs.
    Knerer G; Byford S; Johnson T; Seivewright H; Tyrer P
    Acta Psychiatr Scand; 2005 Sep; 112(3):224-32. PubMed ID: 16095478
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.